NORTHPOND VENTURES GP, LLC sold 93.7% of their position (2.49M shares) of DICE THERAPEUTICS, INC. on the open market
Open‑market sale worth $115.92M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/23/2023ACC: 0000899243-23-016413
10% Owner
Since Sep 2021
-2.49M
Net shares
Net seller
$115.92M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.49M disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−1.97M
Price / share
$46.50
Trade value
$91.58M
% of position
75.7%
6/22/2023
2.60M→633.71K
Common Stock
Indirect
Shares
−523.50K
Price / share
$46.50
Trade value
$24.34M
% of position
75.9%
6/22/2023
689.80K→166.29K
Total
Net shares
−2.49M
Net value
-$115.92M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/22/2023 | S · Sale | −1.97M | $46.50 | $91.58M | 75.7% | 2.60M | 633.71K |
| Common Stock Indirect | 6/22/2023 | S · Sale | −523.50K | $46.50 | $24.34M | 75.9% | 689.80K | 166.29K |
| Total | −2.49M | -$115.92M | ||||||
Derivative Transactions0
No derivative transactions reported